Standout Papers

Molecular portraits of human breast tumours 2000 2026 2008 2017 11.4k
  1. Molecular portraits of human breast tumours (2000)
    Charles M. Perou, Thérese Sørlie et al. Nature
  2. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications (2001)
    Thérese Sørlie, Charles M. Perou et al. Proceedings of the National Academy of Sciences
  3. Repeated observation of breast tumor subtypes in independent gene expression data sets (2003)
    Thérese Sørlie, Robert Tibshirani et al. Proceedings of the National Academy of Sciences
  4. Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes (2009)
    Joel S. Parker, Michael E. Mullins et al. Journal of Clinical Oncology
  5. Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study (2006)
    Lisa A. Carey, Charles M. Perou et al. JAMA
  6. Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma (2004)
    Torsten O. Nielsen, Forrest D. Hsu et al. Clinical Cancer Research
  7. Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer (2009)
    Maggie C.U. Cheang, Stephen Chia et al. JNCI Journal of the National Cancer Institute
  8. The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes (2007)
    Lisa A. Carey, Elizabeth Claire Dees et al. Clinical Cancer Research
  9. Systematic variation in gene expression patterns in human cancer cell lines (2000)
    Douglas T. Ross, Uwe Scherf et al. Nature Genetics
  10. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer (2010)
    Aleix Prat, Joel S. Parker et al. Breast Cancer Research
  11. Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy (2005)
    Roman Rouzier, Charles M. Perou et al. Clinical Cancer Research
  12. Identification of Genes Periodically Expressed in the Human Cell Cycle and Their Expression in Tumors (2002)
    Michael L. Whitfield, Gavin Sherlock et al. Molecular Biology of the Cell
  13. Genome-wide analysis of DNA copy-number changes using cDNA microarrays (1999)
    Jonathan R. Pollack, Charles M. Perou et al. Nature Genetics
  14. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers (1999)
    Charles M. Perou, Stefanie S. Jeffrey et al. Proceedings of the National Academy of Sciences
  15. Diversity of gene expression in adenocarcinoma of the lung (2001)
    Mitchell Garber, Olga G. Troyanskaya et al. Proceedings of the National Academy of Sciences
  16. Concordance among Gene-Expression–Based Predictors for Breast Cancer (2006)
    Huihui Fan, Daniel Oh et al. New England Journal of Medicine
  17. Deconstructing the molecular portraits of breast cancer (2010)
    Aleix Prat, Charles M. Perou Molecular Oncology
  18. Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype (2008)
    Maggie C.U. Cheang, David Voduc et al. Clinical Cancer Research
  19. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors (2002)
    Jonathan R. Pollack, Thérese Sørlie et al. Proceedings of the National Academy of Sciences
  20. MapSplice: Accurate mapping of RNA-seq reads for splice junction discovery (2010)
    Kai Wang, Darshan Singh et al. Nucleic Acids Research
  21. Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma (2005)
    Chad Livasy, Gamze Karaca et al. Modern Pathology
  22. Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update (2020)
    Kimberly H. Allison, M. Elizabeth H. Hammond et al. Journal of Clinical Oncology
  23. Epidemiology of basal-like breast cancer (2007)
    Robert C. Millikan, Beth Newman et al. Breast Cancer Research and Treatment
  24. A custom microarray platform for analysis of microRNA gene expression (2004)
    J. Michael Thomson, Joel S. Parker et al. Nature Methods
  25. Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Response Rates in Stage II to III Triple-Negative Breast Cancer: CALGB 40603 (Alliance) (2014)
    William M. Sikov, Donald A. Berry et al. Journal of Clinical Oncology
  26. Allele-specific copy number analysis of tumors (2010)
    Peter Van Loo, Silje Nord et al. Proceedings of the National Academy of Sciences
  27. A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor–Positive Breast Cancer (2010)
    Torsten O. Nielsen, Joel S. Parker et al. Clinical Cancer Research
  28. Genome-wide analysis of DNA copy number variation in breast cancer using DNA microarrays (1999)
    Jonathan R. Pollack, Charles M. Perou et al. Nature Genetics
  29. MR Imaging Radiomics Signatures for Predicting the Risk of Breast Cancer Recurrence as Given by Research Versions of MammaPrint, Oncotype DX, and PAM50 Gene Assays (2016)
    Hui Li, Yitan Zhu et al. Radiology
  30. Quantitative MRI radiomics in the prediction of molecular classifications of breast cancer subtypes in the TCGA/TCIA data set (2016)
    Hui Li, Yitan Zhu et al. npj Breast Cancer

Immediate Impact

6 by Nobel laureates 54 from Science/Nature 164 standout
Sub-graph 1 of 18

Citing Papers

Tertiary lymphoid structures in cancer
2022 StandoutScience
Phase separation drives aberrant chromatin looping and cancer development
2021 StandoutNature
7 intermediate papers

Works of Charles M. Perou being referenced

B Cells and T Follicular Helper Cells Mediate Response to Checkpoint Inhibitors in High Mutation Burden Mouse Models of Breast Cancer
2019
MapSplice: Accurate mapping of RNA-seq reads for splice junction discovery
2010 Standout
and 7 more

Author Peers

Author Last Decade Papers Cites
Charles M. Perou 38689 38398 39623 485 80.6k
Gabriel N. Hortobágyi 53018 36270 22479 1.1k 86.1k
Ian O. Ellis 27787 26157 20054 971 58.9k
Gordon B. Mills 26097 20496 56742 1.0k 87.5k
John D. Minna 26002 13132 41701 784 72.6k
Adrian L. Harris 34514 45128 64085 1.2k 108.2k
Adi F. Gazdar 27996 12453 36023 641 69.7k
Mien‐Chie Hung 27578 13565 42788 740 66.0k
Chris Sander 13143 25841 67938 304 90.9k
Curtis C. Harris 21985 24469 40543 571 65.7k
Matt van de Rijn 18943 16067 22854 250 49.3k

All Works

Loading papers...

Rankless by CCL
2026